Baker Chad R Gilead Sciences, Inc. Transaction History

Baker Chad R

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $938,370 - $1.22 Million	-15,500 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $1.13 Million - $1.38 Million	15,500 New	15,500 $1.17 Million

1,880

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Baker Chad R, based on Form 13F filings with the SEC.

Stay updated on Baker Chad R with notifications on news.